ISRCTN15172592进行中（未招募）未知
Effect of oral administration of resveratrol on markers of oxidative stress, inflammation and cognitive functions in a population of older adults with type 2 diabetes mellitus
ational Autonomous University of Mexico0 个研究点目标入组 120 人开始时间: 2021年9月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Clinical diagnosis of diabetes mellitus type 2
- •2. People over 60 years of age
- •3. Residence in Mexico City
- •4. Either sex
排除标准
- •1. Smoking or alcoholism
- •2. People who have taken antioxidant supplements or anti-inflammatories in the last 6 months
- •3. Without replacement hormones, in the case of women
研究者
相似试验
已完成
3 期
Investigating the effect of resveratrol on polycystic ovary syndromePolycystic ovary syndrome.Polycystic ovary syndromeE28.2IRCT20221106056417N1Tehran University of Medical Sciences56
已完成
3 期
Evaluation of the effects of resveratrol in patients with Covid ??Covid-19.COVID-19, virus identifiedIRCT20111119008129N13Boushehr University of Medical Sciences140
尚未招募
不适用
Effect of Sublingual Supplementation with Resveratrol in patients with Renal DiseaseHemodialysisInflammationOxidative stress.N18.0Chronic Kidney DiseaseE02.870.300C23.550.470G03.673RBR-43mg87niversidade do Sul de Santa Catarina
招募中
3 期
Resveratrol in COVID19IRCT20200112046089N1Ahvaz University of Medical Sciences50
已完成
2 期
Evaluation of the effects of Resveratrol Supplementation on Hepatic Enzymes, Inflammatory Factors, Lipid profile, blood glucose, Insulin Sensitivity, and Hepatic fibrosis in patients with Nonalcoholic Fatty Liver Disease.on Alcoholic Fatty Liver.Inflammatory liver disease, unspecifiedIRCT201202014010N7ational Nutrition and Food Technology Research Institute50